Clinical Trial Detail

NCT ID NCT02299518
Title Selinexor and Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bhavana Bhatnagar
Indications

acute myeloid leukemia

Therapies

Etoposide

Selinexor

Cytarabine + Etoposide + Mitoxantrone

Age Groups: adult

No variant requirements are available.